ELISA & Rapid Tests to Detect Organ Injury

Argutus Medical are a leader in the manufacture and development of ELISA assays and Rapid Tests for some of the world’s most interesting kidney and liver biomarkers.
We specialise in kidney biomarker tests and provide a complete panel of tests for acute kidney injury (AKI) detection.
Whether used individually or together, our tests can provide a complete picture of where AKI is occurring and where healthy kidney still remains.

Combined use of site-specific biomarkers and serum creatinine has a number of advantages:

• Measure Nephrotoxicity early
• Locate the site of the injury
• Enable better diagnosis
• Improve drug development and ultimately patient care

Site Specific Biomarker ELISA assays & Rapid Tests for nephrotoxicity, renal injury, acute kidney injury


 

 

 

 

 

 

 

  

 

Discover our range of ELISA and Rapid Tests here

 OxyDNA Test - FOR OXiDATIVE DNA DAMAGE

We also offer OxyDNA, a unique test for Oxidative DNA damage. OxyDNA reliably detects 8-oxoguanine (8OG), a breakdown product of oxidative DNA damage and has many potential uses including in cancer, diabetes and fertility research.

Learn more about the novel OxyDNA Test here

 

Latest Tweet from Argutus




Argutus Medical's parent company releases annual report

Friday, 20 April 2012

EKF Diagnostics Holdings plc (AIM: EKF), parent company to Argutus Medical, announces its audited final results for the year ended 31 December 2011, a year of continued progress.

Argutus to Undergo ISO 13485 Certification Audit

Thursday, 29 March 2012

We are delighted to announce that we have applied for an ISO 13485 certification audit by the British Standards Institute (BSI) to assess compliance of our Quality Management System.

Happy World Kidney Day!

Thursday, 08 March 2012

At Argutus Medical we understand the importance of the kidneys and are happy to do our part to raise awareness of kidney health. The video below shows what you can do to look after your kidneys day to day and was created by the people behind World Kidney Day, 8th March. (VIDEO)

EKF Diagnostics granted a patent in the US for HemoPoint H2 cuvettes.

Wednesday, 07 March 2012

Parent Company of Argutus Medical, EKF Diagnostics Holdings plc, announces that it has been granted a patent in the US for HemoPoint H2 cuvettes.

© 2012 Argutus Medical Ltd
  • Trinity Technology & Enterprise Campus Pearse St Dublin 2 Ireland
  • Phone: +353 1 670 8576
  • Fax: +353 1 670 8575
  • Email: info@argutusmed.com

Search

Search - Use spaces to separate your keywords